ArticleFrontiers in oncology2022

Gracillin Shows Potential Efficacy Against Non-Small Cell Lung Cancer Through Inhibiting the mTOR Pathway.

Yamei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.